August 4, 2008

Much Love for CV Therapeutics

CV Therapeutics (CVT) is a MF Rule Breakers pick, who has a nice write up on the company's great second quarter. They also estimate that the company is potentially seriously undervalued.

Zacks appears to agree, noting that a lot of the company's future success hinges on the company's pipeline.

No comments: